Authority certifying the compliance of “Grindeks” final dosage forms –tablets and capsules – with the Saudi Arabia’s medicines manufacturing requirements. The supervising institution of medicinal products in Saudi Arabia issued the certificate after a successful multi-step inspection of JSC “Grindeks” final dosage forms manufacturing site at Krustpils Street 53, Riga. In recent years, JSC “Grindeks” has been strategically expanding the range of oncological medicines therefore medicines of this therapeutic group will be the first with which JSC “Grindeks” plans to enter the Saudi Arabia’s market.